Evidence map›Paper›PMID 40207197›Full record

ArticleUrology case reports2025

First clinical application of the novel 6.3 Fr disposable digital flexible ureteroscope for treatment of lower calyx renal stones in anticoagulated patient.

Xiang Xu, Feihong Xu, Kaifeng Mao, Weiyong Zhong, Mi Zhang, Wenyan Huang, Xiaobao Cheng, Zhenquan Lu, Genggeng Wei

Abstract readCase Reports
In one paragraph

Article in Urology case reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Xiang XuDepartment of Urology, The University of Hong Kong-Shenzhen Hospital, Shenzhen, China.
Feihong XuDepartment of Urology, The University of Hong Kong-Shenzhen Hospital, Shenzhen, China.
Kaifeng MaoDepartment of Urology, The University of Hong Kong-Shenzhen Hospital, Shenzhen, China.
Weiyong ZhongDepartment of Urology, The University of Hong Kong-Shenzhen Hospital, Shenzhen, China.
Mi ZhangDepartment of Urology, The University of Hong Kong-Shenzhen Hospital, Shenzhen, China.
Wenyan HuangDepartment of Urology, The University of Hong Kong-Shenzhen Hospital, Shenzhen, China.
Xiaobao ChengDepartment of Urology, The University of Hong Kong-Shenzhen Hospital, Shenzhen, China.
Zhenquan LuDepartment of Urology, The University of Hong Kong-Shenzhen Hospital, Shenzhen, China.
Genggeng WeiDepartment of Urology, The University of Hong Kong-Shenzhen Hospital, Shenzhen, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Managing urinary tract stones in patients on anticoagulant therapy is challenging due to increased bleeding risks. Flexible ureteroscopy (FURS) offers a low-bleeding-risk alternative. A 75-year-old female on Edoxaban for atrial fibrillation presented with recurrent hematuria and a right renal lower calyx stone. FURS using a 6.3 Fr disposable ureteroscope and 10/12 Fr suctioning ureteral access sheath successfully cleared the stone with no complications. The 6.3 Fr disposable digital flexible ureteroscope is effective for managing renal stones in anticoagulant patients, reducing bleeding risks, ureteral injury, and infection. Further research is needed for broader patient applications.

Indexed as

6.3 Fr flexible ureteroscopeAnticoagulation therapyLow-bleeding-risk surgeryRenal lower calyx stoneStone-free rateTFS-UAS

Identifiers

PMID40207197
PMCPMC11979907

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.